Clinical Trial Update: Anti-PD1-antibody and Pulsed HHI for Advanced BCC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a combination of an anti-PD1 antibody and pulsed hedgehog pathway inhibitor for advanced basal cell carcinoma; the trial is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Anti-PD1 antibody
• Hedgehog pathway inhibitor (HHI)

Snippet

Sponsor: Reinhard Dummer | Conditions: Basal Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING